Financhill
Back

Spyre Therapeutics Stock Predictions

Spyre Therapeutics Stock Forecast

  • Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 78.1% based on the past 8 years of stock performance.
  • Spyre Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
  • Is Spyre Therapeutics Stock Undervalued?
    The current Spyre Therapeutics [SYRE] share price is $34.25. The Score for SYRE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • SYRE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Spyre Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 78.1% based on the past 8 years of stock performance.

Spyre Therapeutics Stock Rating

Sell
44
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics overpriced?

  • Spyre Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%

Spyre Therapeutics Stock Price History

Is SYRE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
spyre.com

52-Week Data

52-Week High:
47.97
52-Week Low:
2.66

Prediction Charts

Market Cap:
1.24B
Price in USD:
34.25
Volume:
175.6K
Beta:
2.61

Technical Analysis

SMA50:
36.35
SMA100:
29.33
SMA200:
21.16
52-Wk Change:
756.25%

Stock Predictions

  • Is Spyre Therapeutics stock public?
    Yes, Spyre Therapeutics is a publicly traded company.
  • What is the Spyre Therapeutics stock quote today?
    The Spyre Therapeutics stock price is 34.25 USD today.
  • How to buy Spyre Therapeutics stock online?
    You can buy Spyre Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-18 34.22 35.61 36.67 33.58
Apr-19 34.10 32.28 35.40 31.97
Apr-22 33.00 33.29 34.39 32.00
Apr-23 33.35 34.21 35.88 32.42
Apr-24 34.17 32.99 34.50 32.20
Apr-25 32.44 32.47 33.23 31.27
Apr-26 32.63 33.56 34.31 32.50
Apr-29 34.03 34.89 35.85 33.41
Apr-30 34.93 33.12 36.65 32.70
May-1 33.01 33.86 34.39 31.39
May-2 35.22 36.28 36.98 33.80
May-3 37.00 35.78 39.04 35.17
May-6 35.97 35.68 37.00 34.98
May-7 35.73 34.25 35.91 33.40

Spyre Therapeutics Earnings

Spyre Therapeutics Earnings Report: Per Share Spyre Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Spyre Therapeutics Forecast Revenue Growth

Spyre Therapeutics Stock Analysis: Historical quarterly revenues per share for Spyre Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.42 per share, an increase this year of $10.15 per share, and a decrease next year of $0.08 per share.

* Spyre Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.